The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
5-chloro-N-(4-(5-(4-vinylphenylsulfonamido)benzo[d]oxazol-2-yl)phenyl)thiophene-2-sulfonamide ID: ALA4533148
PubChem CID: 155547153
Max Phase: Preclinical
Molecular Formula: C25H18ClN3O5S3
Molecular Weight: 572.09
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: C=Cc1ccc(S(=O)(=O)Nc2ccc3oc(-c4ccc(NS(=O)(=O)c5ccc(Cl)s5)cc4)nc3c2)cc1
Standard InChI: InChI=1S/C25H18ClN3O5S3/c1-2-16-3-10-20(11-4-16)36(30,31)29-19-9-12-22-21(15-19)27-25(34-22)17-5-7-18(8-6-17)28-37(32,33)24-14-13-23(26)35-24/h2-15,28-29H,1H2
Standard InChI Key: BMFZKYPZQIDMPH-UHFFFAOYSA-N
Molfile:
RDKit 2D
37 41 0 0 0 0 0 0 0 0999 V2000
28.7627 -19.4227 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
28.7668 -18.6055 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
28.0570 -19.0106 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.5825 -17.6315 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.9952 -18.3414 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
21.4036 -17.6290 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
22.4136 -17.5242 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.4124 -18.3437 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.1205 -18.7527 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.1187 -17.1153 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.7044 -18.7517 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.2883 -18.7546 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.8273 -17.5206 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.8321 -18.3392 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.6121 -18.5876 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.0895 -17.9225 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.6044 -17.2631 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
25.9067 -17.9177 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.3168 -18.6241 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.1333 -18.6196 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.5385 -17.9090 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.1213 -17.2014 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.3063 -17.2093 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.3557 -17.9031 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.5840 -18.6055 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.0679 -19.2640 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
30.8452 -19.0114 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.8451 -18.1942 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.0679 -17.9418 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.5063 -19.4918 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
19.5773 -18.3474 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8709 -18.7600 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8749 -19.5796 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.5912 -19.9850 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.2947 -19.5701 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1700 -19.9930 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4595 -19.5892 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
5 4 2 0
6 5 2 0
7 8 2 0
8 9 1 0
9 14 2 0
13 10 2 0
10 7 1 0
8 11 1 0
11 5 1 0
5 12 1 0
13 14 1 0
14 15 1 0
15 16 2 0
16 17 1 0
17 13 1 0
16 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 18 1 0
21 24 1 0
24 2 1 0
2 25 1 0
25 26 1 0
26 27 1 0
27 28 2 0
28 29 1 0
29 25 2 0
27 30 1 0
12 31 2 0
31 32 1 0
32 33 2 0
33 34 1 0
34 35 2 0
35 12 1 0
33 36 1 0
36 37 2 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 572.09Molecular Weight (Monoisotopic): 571.0097AlogP: 6.45#Rotatable Bonds: 8Polar Surface Area: 118.37Molecular Species: ACIDHBA: 7HBD: 2#RO5 Violations: 2HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): 2CX Acidic pKa: 6.11CX Basic pKa: 0.82CX LogP: 5.77CX LogD: 4.82Aromatic Rings: 5Heavy Atoms: 37QED Weighted: 0.22Np Likeness Score: -1.72
References 1. Washburn A, Abdeen S, Ovechkina Y, Ray AM, Stevens M, Chitre S, Sivinski J, Park Y, Johnson J, Hoang QQ, Chapman E, Parish T, Johnson SM.. (2019) Dual-targeting GroEL/ES chaperonin and protein tyrosine phosphatase B (PtpB) inhibitors: A polypharmacology strategy for treating Mycobacterium tuberculosis infections., 29 (13): [PMID:31047750 ] [10.1016/j.bmcl.2019.04.034 ]